Stay updated with breaking news from Nasdaq Glpg. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Galapagos (NASDAQ:GLPG – Free Report) had its price target reduced by Morgan Stanley from $42.00 to $40.00 in a report issued on Monday, Benzinga reports. They currently have an equal weight rating on the biotechnology company’s stock. A number of other research firms also recently weighed in on GLPG. UBS Group started coverage on shares […]
Shares of Galapagos NV (NASDAQ:GLPG – Get Free Report) have been assigned an average rating of “Hold” from the seven analysts that are presently covering the firm, MarketBeat reports. Six analysts have rated the stock with a hold recommendation and one has issued a buy recommendation on the company. The average twelve-month price target among […]
Galapagos NV (NASDAQ:GLPG – Free Report)’s stock price crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $41.06 and traded as low as $40.27. Galapagos shares last traded at $40.53, with a volume of 95,830 shares traded. Analyst Upgrades and Downgrades […]
UBS Group initiated coverage on shares of Galapagos (NASDAQ:GLPG – Get Rating) in a report released on Wednesday morning, The Fly reports. The firm issued a neutral rating on the biotechnology company’s stock. Other research analysts have also recently issued research reports about the stock. Royal Bank of Canada reduced their price target on shares […]
Finepoint Capital LP grew its position in shares of Galapagos NV (NASDAQ:GLPG – Get Rating) by 2.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 390,359 shares of the biotechnology company’s stock after acquiring an additional 10,657 shares during the […]